Patients with a hereditary risk for cancer have up to a 100 percent ²⁶ chance of developing cancer by age 70. Genetic testing can make a difference in this patient population. Research has shown that increased surveillance, chemoprevention, and prophylactic surgery can significantly reduce morbidity and mortality in patients with inherited cancer gene mutations. Genetic testing can accurately identify high-risk patients so that appropriate medical management options can be considered.

Learn about medical management for patients with a hereditary risk of breast/ovarian cancer.

Learn about medical management for patients with a hereditary risk of colorectal cancer: HNPCC.

Learn about medical management for patients with a hereditary risk of colorectal cancer: FAP.

Learn about medical management for patients with a hereditary risk of melanoma.